# Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome

> **NCT05421208** · NA · RECRUITING · sponsor: **Vanderbilt University Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Post-acute COVID-19 Syndrome
- Postural Tachycardia Syndrome (POTS)
- Long COVID
- SARS CoV 2 Infection

## Interventions

- **DIAGNOSTIC_TEST:** Levels of inflammatory cytokine ( IL-6) in post-COVID-19 POTS and controls
- **DIAGNOSTIC_TEST:** Levels of inflammatory cytokine ( IL-6) in controls
- **DIAGNOSTIC_TEST:** Effect on inflammation after chronic PNS stimulation

## Key facts

- **NCT ID:** NCT05421208
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05421208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05421208, "Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05421208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*